Pharma Journalist 9038 posts 0 comments

Assembly Biosciences, Inc. and Door Pharmaceuticals, LLC announced that the companies have signed an exclusive, two-year collaboration and option agreement focused on the development of…
Read More...

Aeterna Zentaris Inc. a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that, through a wholly-owned subsdiary, it…
Read More...

Merck known as MSD outside of the United States and Canada, announced a collaboration with the Bill & Melinda Gates Foundation (the foundation) where the foundation is committing to…
Read More...

Lead Pharma, a clinical stage pharmaceutical company, designing and developing innovative medicines for the treatment of immune mediated diseases and cancer, announced that it has…
Read More...

Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market Amsterdam, 17 November 2020: CPhI & P-MEC China returns as a…
Read More...

Olema Oncology, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women's cancers, announced a clinical…
Read More...

The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen Pharmaceutical…
Read More...

SMi Reports: The 2021 conference is set to explore the latest developments in RNA delivery agents and RNA-based therapeutics RNA therapeutics is a rapidly expanding industry with…
Read More...

Taiho Pharmaceutical Co., Ltd and Lung Therapeutics, Inc. announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently…
Read More...

Jubilant Therapeutics Inc. a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, and OneThree Biotech, a…
Read More...